Drug
Insulin Lispro Aabc
Insulin Lispro Aabc: highest development phase Post-Market, developed by Eli Lilly. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Eli Lilly
Trials
| Drug | Phase | Indication |
|---|---|---|
| Insulin Lispro-aabc NCT06370715 | Post-Market | Diabetes Mellitus, Type 2 |
Latest
No recent events.
Follow Insulin Lispro Aabc on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.